Back to video list Back to Home Eptinezumab – an efficacious, fast and sustained anti-CGRP monoclonal antibody therapy for preventive migraine treatment You may also like Parkinson's Disease Congress highlights Article Parkinson’s disease – early detection and risk stratification Mental Health Article Practical support for mental health in time of crisis Migraine Satellite symposium Article Assessing patient disability is vital for successful treatment of migraine Schizophrenia Congress highlights Article Improving outcomes for patients with schizophrenia – Patient centric approach